Showing results (41-50 of 175) with videos related to
Sort By:
Pageof 18
Leukemia|June 2, 2021
STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylationDaehong Kim, Giljun Park, Jani Huuhtanen, et al.Oncotarget|April 21, 2017
The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patientsClaudia Schubert, Nicolas Chatain, Till Braunschweig, et al.Blood Advances|June 23, 2026
Single-Cell Analysis of Adaptive NK and CMV-Specific T Cell Dynamics after Allogeneic HSCTAino Elina Hakkinen, Jani Huuhtanen, Sofie Lundgren, et al.Leukemia|January 13, 2019
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALLHelena Hohtari, Oscar Brück, Sami Blom, et al.Orphanet Journal of Rare Diseases|November 28, 2018
Immune cell phenotype and functional defects in Netherton syndromeElina Eränkö, Mette Ilander, Mirja Tuomiranta, et al.Leukemia|August 23, 2025
Predicting antigen-specific T-cell immunity against Wilms tumor 1 in hematologic cancerBrittany L Ford, Emmi Jokinen, Jani Huuhtanen, et al.Leukemia Research|February 15, 2020
Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapyStina Söderlund, Inger Persson, Mette Ilander, et al.Cancer|March 22, 2016
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicityCharles A Schiffer, Jorge E Cortes, Andreas Hochhaus, et al.Leukemia & Lymphoma|January 29, 2011
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitorsJohn J Powers, Jason A Dubovsky, P K Epling-Burnette, et al.Oncoimmunology|January 10, 2022
T and NK cell abundance defines two distinct subgroups of renal cell carcinomaMoon Hee Lee, Petrus Järvinen, Harry Nísen, et al.Pageof 18